Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malaysia Biotech Industry Lags In Expected Growth

This article was originally published in PharmAsia News

Executive Summary

Malaysia's experiment in building a biotechnology industry is lagging behind initial goals as the government approaches the second five-year phase set to begin in 2011. Plans call for the biotech industry to more than double its share of the economy to 2.5 percent within the 2011-2016 period. Since the National Biotechnology Policy was adopted in 2005, the biotech industry has grown only enough to constitute 1 percent of gross domestic product. The head of the government's Malaysia Biotechnology Corp said the nation needs more cooperation between researchers and industry players. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072265

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel